Monthly Archives: September 2018

Zavation Medical Products, LLC, a LongueVue Capital Portfolio Company, Completes Investment in Pan Medical U.S. Corp.

JACKSON, Miss., Sept. 18, 2018 /PRNewswire/ -- Zavation Medical Products ("Zavation"), a LongueVue Capital ("LVC") portfolio company, is pleased to announce it has partnered with the management team of Pan Medical U.S. Corp ("PanMed" or the "Company") to acquire the Company. This partnership broadens Zavation's service offering by adding a full suite of minimally invasive products, including the

By |2018-09-18T17:30:52+00:00September 18th, 2018|Financial|
Read More

Meditech Spine Receives FDA Clearance for its Cure™ Opel-C Plating System

ATLANTA, Sept. 18, 2018 /PRNewswire/ -- Meditech Spine has received FDA 510(k) clearance to market the Cure™ Opel-C Plate System, an add-on technology to its already cleared CURE™ ACP System and Talos®-C (HA) Interbody Systems. With this approval, Meditech will now offer two additional CURE™ ACP plating options with its Talos® line of cervical interbodies made with the

By |2018-09-18T16:53:29+00:00September 18th, 2018|Regulatory, Spine, Top Stories|
Read More

OrthoPediatrics Corp. Announces First PNP | FEMUR Cases Performed in Australia

WARSAW, Ind., Sept. 17, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the first surgeries in Australia utilizing the new Pediatric Nailing Platform | FEMUR (“PNP | FEMUR”).  OrthoPediatrics’ sales agent in Australia and New Zealand is Surgical Specialties,

By |2018-09-18T16:21:14+00:00September 18th, 2018|Extremities|
Read More

Osiris Therapeutics, Inc. Announces GrafixPL PRIME™ Launches October 1, 2018

COLUMBIA, Md., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announces that GrafixPL PRIME™, a human placental membrane that can be stored at ambient temperatures, launches for sale on October 1, 2018.  The structural matrix, growth factors,

By |2018-09-18T16:03:05+00:00September 18th, 2018|Biologics|
Read More

SpineVision® Receives CE Mark for Next-Gen P.L.U.S.® Deformity-Correction Spinal System

ANTONY, France--(BUSINESS WIRE)--SpineVision announced today that it has received CE mark for its next-generation Pivot Link Universal System (P.L.U.S.) spine deformity-correction system. SpineVision will introduce the next-generation P.L.U.S. to spine surgeons at “EuroSpine 2018” (Booth #24C) in Barcelona, Spain (Sept. 19-21), and “NASS 2018” (Booth #1311) in Los Angeles (Sept. 26-29). Deformity of the spine includes any abnormality of the formation, alignment, or shape of the vertebral

By |2018-09-18T15:29:14+00:00September 18th, 2018|Regulatory, Spine, Top Stories|
Read More

Conformis Announces Settlement of Patent Dispute with Smith & Nephew

 BILLERICA, Mass., Sept. 17, 2018 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that fit each patient’s unique anatomy, announced today that it has entered into a settlement and license agreement with Smith & Nephew that resolves

By |2018-09-17T23:01:06+00:00September 17th, 2018|Regulatory|
Read More

Spine Wave Announces the Commercial Launch of the Paramount® Anterior Cervical Cage

SHELTON, Conn., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Spine Wave is pleased to announce the commercial launch of the Paramount® Anterior Cervical Cage.  The Paramount® Anterior Cervical Cage is a titanium anterior cervical implant with integrated fixation blades.  The patented system offers controlled, less invasive blade deployment and maximized bone grafting.  The Paramount® Anterior Cervical

By |2018-09-17T22:37:11+00:00September 17th, 2018|Spine|
Read More

Simplify® Medical Technology Selected for Innovative Technology Paper at NASS 2018 Annual Meeting

SUNNYVALE, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Simplify Medical Pty Ltd, maker of the Simplify® cervical artificial disc, announced today that an abstract for preliminary data from the Company’s 1-level Investigational Device Exemption (IDE) clinical trial has been selected as an Innovative Technology Presentation during the 2018 North American Spine Society (NASS) Annual Meeting,

By |2018-09-17T17:24:40+00:00September 17th, 2018|Spine|
Read More

SpineVision® Receives FDA Clearance and CE Mark for Next-Gen Titanium 3D-Printed HEXANIUM TLIF Cage

September 17, 2018 ANTONY, France--(BUSINESS WIRE)--SpineVision announced today that it has received FDA clearance and CE mark for its next-generation titanium 3D laser-printed HEXANIUM TLIF (Transforaminal Lumbar Interbody Fusion) cage for back surgery. SpineVision will introduce its new product to spine surgeons at “EuroSpine 2018”(Booth #24C) in Barcelona, Spain (Sept. 19-21), and “NASS 2018” (Booth #1311) in Los Angeles (Sept. 26-29). Spine fusion surgery is often

By |2018-09-17T14:55:44+00:00September 17th, 2018|Regulatory, Spine, Top Stories|
Read More

Bone Therapeutics SA announces final results from Phase I/IIA ALLOB delayed-union fracture study

Gosselies, Belgium, 14 September 2018, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces positive final results in the Phase I/IIA delayed-union study of its allogeneic bone cell therapy product ALLOB in 21 patients, supporting the future

By |2018-09-14T22:25:09+00:00September 14th, 2018|Biologics|
Read More
Odysseus Medical Solutions 2018
RssEmail